Papers
2
Total Citations
24
H-Index
2
About
Dr. Shih‐Min Yin is a pioneering surgeon-scientist whose research focuses on advancing minimally invasive surgical techniques for pancreatic cancer, particularly through robotic-assisted procedures. His major contributions center on demonstrating the feasibility and safety of complex robotic pancreaticoduodenectomy, even in cases requiring vascular resection or reconstruction—traditionally considered contraindications for minimally invasive approaches. In his landmark 2022 study, Dr. Yin compared robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma, reporting comparable surgical and oncological outcomes from a pilot experience (22 citations). This work challenges conventional surgical paradigms and expands the role of robotics in high-risk hepatobiliary surgery. Additionally, his 2020 case report established that robotic pancreaticoduodenectomy with hepatic artery reconstruction is both feasible and safe for patients with type 9 hepatic arterial anatomy (2 citations), addressing a previously unstudied technical challenge. Dr. Yin’s work is notable for its translational impact, offering patients potentially reduced recovery times without compromising cancer clearance. His research continues to push the boundaries of what is achievable with robotic platforms in pancreatic surgery, making him a key figure in the evolution of minimally invasive oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2